StartseitevorwärtsAktienvorwärtsCapricor TherapeuticsvorwärtsNachrichten
    Capricor Therapeutics Aktie
    Aktie
    ISIN: US14070B3096 WKN: A2PLU4 SYM: CAPR Land Flagge US USA
    Zur Watchlist hinzufügenZur Watchlist hinzufügen Zum Portfolio hinzufügenZum Portfolio hinzufügen
    5,8800
     
    USD
    +0,17 %
    +0,0100 USD
    Letzter Kurs 11:52:00 Nasdaq

    Capricor Therapeutics Aktie kaufen

    Geldkurs
    12.11.25
    5,8800
     
    USD
    1.200 STK
    Briefkurs
    12.11.25
    5,9000
     
    USD
    8.900 STK
    Verkauf
    Kauf
    BEI SMARTBROKER+ HANDELN
    Hinweis
    Verlängerte Handelszeiten
    Ab sofort von 07:30 bis 23:00 Uhr
    Baader Tragding

    Neueste Nachrichten

    Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    10.11.25 · globenewswire · Capricor TherapeuticsEnglische Nachricht
    Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
    03.11.25 · globenewswire · Capricor TherapeuticsEnglische Nachricht
    Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
    31.10.25 · globenewswire · Capricor TherapeuticsEnglische Nachricht
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 25.09.2025
    25.09.25 · wO Chartvergleich · OHB
    Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting
    25.09.25 · globenewswire · Capricor TherapeuticsEnglische Nachricht
    CAPR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR
    16.09.25 · newsfile · Capricor TherapeuticsEnglische Nachricht
    FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR
    15.09.25 · Business Wire (engl.) · Capricor TherapeuticsEnglische Nachricht
    CAPR DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR
    15.09.25 · newsfile · Capricor TherapeuticsEnglische Nachricht
    CAPR IMPORTANT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR
    14.09.25 · newsfile · Capricor TherapeuticsEnglische Nachricht
    CAPR IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR
    13.09.25 · newsfile · Capricor TherapeuticsEnglische Nachricht
    CAPR FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR
    12.09.25 · newsfile · Capricor TherapeuticsEnglische Nachricht
    CAPR DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 15 Deadline in Securities Class Action - CAPR
    11.09.25 · newsfile · Capricor TherapeuticsEnglische Nachricht